NorthWest Biotherapeutics Inc (NWBO)

[hankmanhub]

Yes, I agree Hoff. This is a very limited point on which who issued the "TLD" can make a difference by the self imposed terms of their silence. As I pointed out in an earlier post (reproduced below) I do not hink it will make much difference in terms of market impact, once the very basic information is out, it is out - and reproducing the same information with a little enhancement (unless it is large) will not change much of anything.

I wrote at post #495465 the following:

BB, I only partially agree with you.
Yes the targeted UK approvals are truly important to us at this time (and the EU and the FDA a bit later), but I would not so minimize the importance of the JA and the ASM. These are quite important in their own right and every brick in the foundation is important. I agree on the order of their importance however. While a good ASM can help, a bad ASM can truly hurt. So please do not write this off as unimportant. The JA remains a key element in the credibility of the company, the trial and the science and its ability to produce what they promise (both wrt the JA and the trial)..